Adam T. Klauder

Clifford Chance

Contact Info

Website

Recently by Adam T. Klauder

Anti-Corruption

Medical Device Companies: Testing FCPA Compliance Program Effectiveness In Emerging Markets

Stephen M. Nickelsburg, Adam T. Klauder, Simone M. Peek | Clifford Chance

Medical device companies that do business in emerging markets face the prospect of great reward as well as great risk. Increasingly, one of the major risks is exposure to the U.S. Foreign Corrupt Practices Act ("FCPA") and similar international anti-bribery laws and regulations. A key...

SEE ALL COMPANY Articles